Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand.

The New Zealand medical journal - 26 Nov 2010

Muir Lauretta A, George Peter M, Laurie Andrew D, Reid Nicola, Whitehead Lisa

Abstract excerpt

AIM: To identify the diagnostic and treatment rates for familial hypercholesterolaemia (FH) in New Zealand. METHODS: The FH data held by Canterbury Health Laboratories and the Canterbury District Health Board lipid clinic was examined to give an indication of the level of identification and treatment of FH in both Canterbury and New Zealand. RESULTS: Between 2004-08, 588 people, out of a possible 10,500 affected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to APOB gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to LDLR gene

Share to Hypercholesterolemia

Share to Mass Screening

Share to Mutation

Share to New Zealand

Share to Risk Factors

Source

Identifiers

PMID: 21326404

Genes

APOB
LDLR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand.PMID 21326404Read ↗

Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.Semantic proximity Read ↗

Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.Semantic proximity Read ↗

Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.Semantic proximity Read ↗

Familial hypercholesterolaemia: a pressing issue for European health care.Semantic proximity Read ↗

A Scoping Review of Approaches for the Detection and Management of Familial Hypercholesterolaemia in Primary CareSemantic proximity Read ↗

Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemiaSemantic proximity Read ↗

Improving Familial Hypercholesterolemia Detection Through Implementation of Nurse-led Cascade ScreeningSemantic proximity Read ↗

Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.Semantic proximity Read ↗

Cascade screening for familial hypercholesterolemia: Practical consequences.Semantic proximity Read ↗

Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testingSemantic proximity Read ↗

Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.Semantic proximity Read ↗

Cascade screening for familial hypercholesterolemia should be organized at a national level.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.